Literature DB >> 2144587

Effects of dehydroepiandrosterone treatment in rats with diet-induced obesity.

P F Mohan1, J S Ihnen, B E Levin, M P Cleary.   

Abstract

Previous studies showed that administration of dehydroepiandrosterone (DHEA) to lean and genetically obese Zucker rats reduced body weight. In the present experiments, the effect of DHEA treatment in rats with diet-induced obesity was evaluated. In experiment 1, male Sprague-Dawley rats (300 g) were fed a nonpurified diet (reference group) or a condensed milk-corn oil nonpurified diet [diet-induced obese (DIO) rats] for 7 wk. Then, 0.6% DHEA was included in the food of one-half of the DIO rats (DIO + DHEA rats). After 6 wk, DIO rats weighed 23% more and had greater fat pad weights, cell size and cell number than reference and DIO + DHEA rats. Brown fat mitochondrial respiration was similar in all groups. DIO rats had higher serum cholesterol and triacylglycerol concentrations than reference and DIO + DHEA rats. DIO + DHEA rats had lower serum insulin levels than DIO and reference rats. In experiment 2, male Sprague-Dawley rats (460 g) were fed either the nonpurified diet or the condensed milk diet for 8 wk. Condensed milk-fed rats were then divided into DIO and diet-resistant groups. One-half of the rats in each group were fed 0.6% DHEA for 2 wk. Body weights and serum glucose, insulin, triacylglycerol and triiodothyronine levels were lowered by DHEA treatment in all groups. Liver mitochondrial state 3 respiration rates per gram and per liver and peroxisomal beta-oxidation were higher in DHEA-treated than in control rats. In DIO rats, DHEA treatment appears to interfere with hyperplastic adipose tissue growth. In this strain of rats, DHEA appears to have hypolipidemic and hypoinsulinemic effects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144587     DOI: 10.1093/jn/120.9.1103

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  7 in total

1.  Dehydroepiandrosterone and human adipose tissue.

Authors:  F Saraç; S Yildiz; F Saygili; G Ozgen; C Yilmaz; T Kabalak; M Tüzün
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

2.  Concerning the mechanism of increased thermogenesis in rats treated with dehydroepiandrosterone.

Authors:  V Bobyleva; N Kneer; M Bellei; D Battelli; H A Lardy
Journal:  J Bioenerg Biomembr       Date:  1993-06       Impact factor: 2.945

3.  Dehydroepiandrosterone (DHEA) prevents the prostanoid imbalance in mesenteric bed of fructose-induced hypertensive rats.

Authors:  Horacio A Peredo; Marcos Mayer; Ileana R Faya; Ana M Puyó; Andrea Carranza
Journal:  Eur J Nutr       Date:  2008-08-25       Impact factor: 5.614

Review 4.  A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial?

Authors:  Nikolaos Samaras; Dimitrios Samaras; Emilia Frangos; Alexandre Forster; Jacques Philippe
Journal:  Rejuvenation Res       Date:  2013-08       Impact factor: 4.663

5.  DHEA administration and exercise training improves insulin resistance in obese rats.

Authors:  Koji Sato; Motoyuki Iemitsu; Katsuji Aizawa; Noboru Mesaki; Ryuichi Ajisaka; Satoshi Fujita
Journal:  Nutr Metab (Lond)       Date:  2012-05-30       Impact factor: 4.169

6.  Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans.

Authors:  Edward P Weiss; Dennis T Villareal; Luigi Fontana; Dong-Ho Han; John O Holloszy
Journal:  Aging (Albany NY)       Date:  2011-05       Impact factor: 5.682

7.  The effect of androgens on ovarian follicle maturation: Dihydrotestosterone suppress FSH-stimulated granulosa cell proliferation by upregulating PPARγ-dependent PTEN expression.

Authors:  Mei-Jou Chen; Chia-Hung Chou; Shee-Uan Chen; Wei-Shiung Yang; Yu-Shih Yang; Hong-Nerng Ho
Journal:  Sci Rep       Date:  2015-12-17       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.